The Latest Breaking News from Disease

In today’s newsletter: A gene therapy trial has successfully treated Huntington’s for the first time – one of several recent groundbreaking medical advances bringing hope in gloomy times

Winsights.life envisions a HIPAA-protected space where families own their health data, track their child's progress, and connect with others navigating similar conditions.

Shares of Capricor Therapeutics Inc. (NASDAQ: CAPR) are up Thursday after the company announced progress regarding one of its rare disease therapeutics. The biotech company’s stock jumped 18% immediately following the news.

Epizootic hemorrhagic disease is killing white-tailed deer in states like Maryland, Virginia, Pennsylvania, and West Virginia

UniQure NV (NASDAQ: QURE) just staged one of biotech's wildest rides of the year, soaring 248% in a single session after unveiling successful trial results for its experimental Huntington's disease gene therapy. Indeed, the stock reached a 5-year high, marking its best session ever. But if you think the move…

COMMENT: In 2021, a few years after her father started showing symptoms, Carly Evans tested positive for the Huntington’s disease gene. She writes about the fatal condition that has affected generations of her family, and the hope this week’s breakthrough brings

It is the first time a drug trial has slowed the rare disorder’s progression in an ongoing, significant way, researchers said.

Public health leaders worry proposed 53% CDC slash would weaken disease prevention and pose a national security risk

With millions of vapers across the UK, experts raise concerns about the impact of vaping on oral health, including potential tooth decay and gum disease